Ultragenyx Valuation
| RARE Stock | USD 38.86 0.78 1.97% |
At this time, the company appears to be undervalued. Ultragenyx has a current Real Value of $52.29 per share. The regular price of the company is $38.86. Our model measures the value of Ultragenyx from inspecting the company fundamentals such as Shares Outstanding of 92.5 M, return on equity of -2.12, and Operating Margin of (0.74) % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Ultragenyx's valuation include:
Price Book 14.3627 | Enterprise Value | Enterprise Value Ebitda (6.46) | Price Sales 6.5451 | Enterprise Value Revenue 5.5282 |
Undervalued
Today
Please note that Ultragenyx's price fluctuation is very steady at this time. Calculation of the real value of Ultragenyx is based on 3 months time horizon. Increasing Ultragenyx's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Ultragenyx stock is determined by what a typical buyer is willing to pay for full or partial control of Ultragenyx. Since Ultragenyx is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ultragenyx Stock. However, Ultragenyx's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 38.86 | Real 52.29 | Target 91.25 | Hype 38.68 | Naive 40.33 |
The real value of Ultragenyx Stock, also known as its intrinsic value, is the underlying worth of Ultragenyx Company, which is reflected in its stock price. It is based on Ultragenyx's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ultragenyx's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ultragenyx helps investors to forecast how Ultragenyx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ultragenyx more accurately as focusing exclusively on Ultragenyx's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Ultragenyx's intrinsic value based on its ongoing forecasts of Ultragenyx's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Ultragenyx's closest peers. If more than one evaluation category is relevant for Ultragenyx we suggest using both methods to arrive at a better estimate.
Ultragenyx Cash |
|
Ultragenyx Valuation Trend
Comparing Ultragenyx's enterprise value against its market capitalization is a good way to estimate the value of Ultragenyx uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Ultragenyx Revenue by Product
Ultragenyx Total Value Analysis
Ultragenyx is at this time projected to have valuation of 3.1 B with market capitalization of 3.67 B, debt of 10.3 M, and cash on hands of 542.8 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Ultragenyx fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.1 B | 3.67 B | 10.3 M | 542.8 M |
Ultragenyx Investor Information
About 98.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 6.29. Ultragenyx had not issued any dividends in recent years. The entity had 1:3 split on the 17th of January 2014. Based on the key measurements obtained from Ultragenyx's financial statements, Ultragenyx is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.Ultragenyx Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ultragenyx has an asset utilization ratio of 37.26 percent. This indicates that the Company is making $0.37 for each dollar of assets. An increasing asset utilization means that Ultragenyx is more efficient with each dollar of assets it utilizes for everyday operations.Ultragenyx Ownership Allocation
Ultragenyx shows a total of 92.5 Million outstanding shares. The majority of Ultragenyx outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Ultragenyx to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Ultragenyx. Please pay attention to any change in the institutional holdings of Ultragenyx as this could imply that something significant has changed or is about to change at the company. Also note that roughly one million six hundred nine thousand five hundred nineteen invesors are currently shorting Ultragenyx expressing very little confidence in its future performance.Ultragenyx Profitability Analysis
The company reported the previous year's revenue of 560.23 M. Net Loss for the year was (569.18 M) with loss before overhead, payroll, taxes, and interest of (214.36 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ultragenyx's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ultragenyx and how it compares across the competition.
About Ultragenyx Valuation
The stock valuation mechanism determines Ultragenyx's current worth on a weekly basis. Our valuation model uses a comparative analysis of Ultragenyx. We calculate exposure to Ultragenyx's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ultragenyx's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 483.5 M | 507.7 M | |
| Pretax Profit Margin | (1.01) | (1.06) | |
| Operating Profit Margin | (0.96) | (1.00) | |
| Net Loss | (1.02) | (1.07) | |
| Gross Profit Margin | 0.86 | 0.91 |
Ultragenyx Growth Indicators
Investing in growth stocks can be very risky. If the company such as Ultragenyx does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 90.5 M |
Ultragenyx Current Valuation Indicators
Valuation refers to the process of determining the present value of Ultragenyx and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Ultragenyx we look at many different elements of the entity such as Ultragenyx's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Ultragenyx, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Ultragenyx's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Ultragenyx's worth.Complementary Tools for Ultragenyx Stock analysis
When running Ultragenyx's price analysis, check to measure Ultragenyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultragenyx is operating at the current time. Most of Ultragenyx's value examination focuses on studying past and present price action to predict the probability of Ultragenyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultragenyx's price. Additionally, you may evaluate how the addition of Ultragenyx to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |